Proposed Fundraise of £28.9m and Cancellation | 10-Apr-2024 | 07:00 | RNS |
Total Voting Rights | 31-Jan-2024 | 16:30 | RNS |
Exercise of Options and Issue of Equity | 24-Jan-2024 | 10:04 | RNS |
Business Update | 16-Jan-2024 | 07:00 | RNS |
Director Dealing and Issue of Equity | 09-Jan-2024 | 16:04 | RNS |
Update on OTCQX Market Listing | 27-Dec-2023 | 07:00 | RNS |
Strategic RWE collaboration with Arcturis | 02-Nov-2023 | 07:00 | RNS |
Interim results for the six months to 31 July 2023 | 26-Oct-2023 | 07:38 | RNS |
Notice of Interim Results | 19-Oct-2023 | 09:54 | RNS |
Senior Management Update | 20-Sep-2023 | 07:00 | RNS |
Exercise of Options and Issue of Equity | 07-Sep-2023 | 11:47 | RNS |
Total Voting Rights | 31-Jul-2023 | 16:30 | RNS |
Result of Annual General Meeting | 18-Jul-2023 | 16:20 | RNS |
Director Dealing and Issue of Equity | 06-Jul-2023 | 17:27 | RNS |
Notice of AGM and Posting of Annual Report | 11-May-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 9.60p |
Change Today | 0.43p |
% Change | 4.63 % |
52 Week High | 23.10p |
52 Week Low | 8.13p |
Volume | 2,228,014 |
Shares Issued | 584.34m |
Market Cap | £56.10m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
10:05 | 560,000 @ 9.00p |
16:15 | 30,000 @ 9.67p |
16:06 | 50,000 @ 9.40p |
16:06 | 65,677 @ 9.35p |
15:26 | 3,761 @ 9.20p |
Chair | Trevor Mervyn Jones |
CEO | Ali Mortazavi |
You are here: research